Novel Autotaxin Inhibitors for the Treatment of Osteoarthritis Pain [electronic resource] : Lead Optimization via Structure-Based Drug Design

 0 Người đánh giá. Xếp hạng trung bình 0

Tác giả:

Ngôn ngữ: eng

Ký hiệu phân loại: 611.5 Human anatomy, cytology, histology

Thông tin xuất bản: Washington, D.C. : Oak Ridge, Tenn. : United States. Dept. of Energy. Office of Science ; Distributed by the Office of Scientific and Technical Information, U.S. Dept. of Energy, 2016

Mô tả vật lý: Size: p. 857-861 : , digital, PDF file.

Bộ sưu tập: Metadata

ID: 260833

 In an effort to develop a novel therapeutic agent aimed at addressing the unmet need of patients with osteoarthritis pain, we set out to develop an inhibitor for autotaxin with excellent potency and physical properties to allow for the clinical investigation of autotaxin-induced nociceptive and neuropathic pain. An initial hit identification campaign led to an aminopyrimidine series with an autotaxin IC<
 sub>
 50<
 /sub>
  of 500 nM. X-ray crystallography enabled the optimization to a lead compound that demonstrated favorable potency (IC<
 sub>
 50<
 /sub>
  = 2 nM), PK properties, and a robust PK/PD relationship.
Tạo bộ sưu tập với mã QR

THƯ VIỆN - TRƯỜNG ĐẠI HỌC CÔNG NGHỆ TP.HCM

ĐT: (028) 71010608 | Email: tt.thuvien@hutech.edu.vn

Copyright @2020 THƯ VIỆN HUTECH